Dr. Reddy's Laboratories Ltd. expands further into consumer health with a £500m ($632m) agreement to acquire rights to OTC nicotine replacement therapy products Haleon plc markets outside the US.
Dr Reddy’s Acquiring Haleon NRTs Available Outside US In Deal Worth Up To $632M
The Indian player made another high-level deal that grants it rights to nicotine replacement therapies in over 30 countries, following on from its recent announcements with Nestlé.
